Bernard Hamelin

Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial

Joel E. Richter, Peter J. Kahrilas, John F. Johanson et al. · The American Journal of Gastroenterology · 2001 · 394 citations

Urology, Esophagus, Gastroenterology +6

Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis.

Elisabetta Cariani, Cantal Lasserre, Danielle Seurin et al. · PubMed · 1988 · 193 citations

Pathology, Liver Carcinogenesis, Tumor Biology +19

Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety

David A. Johnson, Stanley B. Benjamin, Nimish Vakil et al. · The American Journal of Gastroenterology · 2001 · 159 citations

Independent risk factors for hepatocellular carcinoma in french drinkers

Thierry Poynard, Alain Aubert, Y. Lazizi et al. · Hepatology · 1991 · 84 citations · Full text

Hepatitis B, Pathology, Consecutive Drinkers +19

A Multicenter, Randomized, Double-Blind, 8-Week Comparative Trial of Standard Doses of Esomeprazole (40 mg) and Omeprazole (20 mg) for the Treatment of Erosive Esophagitis

Colleen M. Schmitt, Charles J. Lightdale, Clara Hwang et al. · Digestive Diseases and Sciences · 2006 · 60 citations

Esophagus, Pharmacology, Gastroenterology +6